Evaluation of Therapeutic Efficacy and Safety of Tranexamic Acid Local Infiltration in Combination with Topical 4% Hydroquinone Cream Compared to Topical 4% Hydroquinone Cream Alone in Patients with Melasma: A Split-Face Study
Introduction. Melasma is an acquired pigmentary disorder characterized by hyperpigmented macules and/or patches affecting sun-exposed skin. Tranexamic acid (TA) can reduce melanin content of epidermis. Thus, we conducted this study to evaluate the efficacy and safety of tranexamic acid local infiltr...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Dermatology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2018/8350317 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832545714525175808 |
---|---|
author | Zohreh Tehranchinia Bita Saghi Hoda Rahimi |
author_facet | Zohreh Tehranchinia Bita Saghi Hoda Rahimi |
author_sort | Zohreh Tehranchinia |
collection | DOAJ |
description | Introduction. Melasma is an acquired pigmentary disorder characterized by hyperpigmented macules and/or patches affecting sun-exposed skin. Tranexamic acid (TA) can reduce melanin content of epidermis. Thus, we conducted this study to evaluate the efficacy and safety of tranexamic acid local infiltration in combination with topical 4% hydroquinone cream compared to topical 4% hydroquinone cream alone in patients with melasma. Material and Methods. This study was a prospective assessor- and analyst-blind, randomized split-face clinical trial which was performed on patients with bilateral malar epidermal melasma. A total of 55 patients were enrolled, and each side of their face was randomly allocated to either TA+HQ or HQ alone treatment. The MASI score was applied as an objective measurement to compare two treatment groups. The patient's satisfaction of melasma treatment was evaluated using a four-scale grading, as well. Results. The mean of MASI score in week 16 decreased in both groups significantly (p < 0.01). The therapeutic outcomes were significantly better in TA+HQ group than HQ group (p=0.001). Patients satisfaction with treatment was significantly higher in the TA + HQ group. The difference between the two groups regarding side effect occurrence was not statistically significant. Conclusion. Addition of tranexamic acid injections to conventional hydroquinone therapy can increase the efficacy of topical treatment. This trial is registered with IRCT2015110324865N1. |
format | Article |
id | doaj-art-684191b51e714b7c958b1634bca82576 |
institution | Kabale University |
issn | 1687-6105 1687-6113 |
language | English |
publishDate | 2018-01-01 |
publisher | Wiley |
record_format | Article |
series | Dermatology Research and Practice |
spelling | doaj-art-684191b51e714b7c958b1634bca825762025-02-03T07:25:01ZengWileyDermatology Research and Practice1687-61051687-61132018-01-01201810.1155/2018/83503178350317Evaluation of Therapeutic Efficacy and Safety of Tranexamic Acid Local Infiltration in Combination with Topical 4% Hydroquinone Cream Compared to Topical 4% Hydroquinone Cream Alone in Patients with Melasma: A Split-Face StudyZohreh Tehranchinia0Bita Saghi1Hoda Rahimi2Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IranSkin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IranSkin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IranIntroduction. Melasma is an acquired pigmentary disorder characterized by hyperpigmented macules and/or patches affecting sun-exposed skin. Tranexamic acid (TA) can reduce melanin content of epidermis. Thus, we conducted this study to evaluate the efficacy and safety of tranexamic acid local infiltration in combination with topical 4% hydroquinone cream compared to topical 4% hydroquinone cream alone in patients with melasma. Material and Methods. This study was a prospective assessor- and analyst-blind, randomized split-face clinical trial which was performed on patients with bilateral malar epidermal melasma. A total of 55 patients were enrolled, and each side of their face was randomly allocated to either TA+HQ or HQ alone treatment. The MASI score was applied as an objective measurement to compare two treatment groups. The patient's satisfaction of melasma treatment was evaluated using a four-scale grading, as well. Results. The mean of MASI score in week 16 decreased in both groups significantly (p < 0.01). The therapeutic outcomes were significantly better in TA+HQ group than HQ group (p=0.001). Patients satisfaction with treatment was significantly higher in the TA + HQ group. The difference between the two groups regarding side effect occurrence was not statistically significant. Conclusion. Addition of tranexamic acid injections to conventional hydroquinone therapy can increase the efficacy of topical treatment. This trial is registered with IRCT2015110324865N1.http://dx.doi.org/10.1155/2018/8350317 |
spellingShingle | Zohreh Tehranchinia Bita Saghi Hoda Rahimi Evaluation of Therapeutic Efficacy and Safety of Tranexamic Acid Local Infiltration in Combination with Topical 4% Hydroquinone Cream Compared to Topical 4% Hydroquinone Cream Alone in Patients with Melasma: A Split-Face Study Dermatology Research and Practice |
title | Evaluation of Therapeutic Efficacy and Safety of Tranexamic Acid Local Infiltration in Combination with Topical 4% Hydroquinone Cream Compared to Topical 4% Hydroquinone Cream Alone in Patients with Melasma: A Split-Face Study |
title_full | Evaluation of Therapeutic Efficacy and Safety of Tranexamic Acid Local Infiltration in Combination with Topical 4% Hydroquinone Cream Compared to Topical 4% Hydroquinone Cream Alone in Patients with Melasma: A Split-Face Study |
title_fullStr | Evaluation of Therapeutic Efficacy and Safety of Tranexamic Acid Local Infiltration in Combination with Topical 4% Hydroquinone Cream Compared to Topical 4% Hydroquinone Cream Alone in Patients with Melasma: A Split-Face Study |
title_full_unstemmed | Evaluation of Therapeutic Efficacy and Safety of Tranexamic Acid Local Infiltration in Combination with Topical 4% Hydroquinone Cream Compared to Topical 4% Hydroquinone Cream Alone in Patients with Melasma: A Split-Face Study |
title_short | Evaluation of Therapeutic Efficacy and Safety of Tranexamic Acid Local Infiltration in Combination with Topical 4% Hydroquinone Cream Compared to Topical 4% Hydroquinone Cream Alone in Patients with Melasma: A Split-Face Study |
title_sort | evaluation of therapeutic efficacy and safety of tranexamic acid local infiltration in combination with topical 4 hydroquinone cream compared to topical 4 hydroquinone cream alone in patients with melasma a split face study |
url | http://dx.doi.org/10.1155/2018/8350317 |
work_keys_str_mv | AT zohrehtehranchinia evaluationoftherapeuticefficacyandsafetyoftranexamicacidlocalinfiltrationincombinationwithtopical4hydroquinonecreamcomparedtotopical4hydroquinonecreamaloneinpatientswithmelasmaasplitfacestudy AT bitasaghi evaluationoftherapeuticefficacyandsafetyoftranexamicacidlocalinfiltrationincombinationwithtopical4hydroquinonecreamcomparedtotopical4hydroquinonecreamaloneinpatientswithmelasmaasplitfacestudy AT hodarahimi evaluationoftherapeuticefficacyandsafetyoftranexamicacidlocalinfiltrationincombinationwithtopical4hydroquinonecreamcomparedtotopical4hydroquinonecreamaloneinpatientswithmelasmaasplitfacestudy |